leaders-02

Pancreatic Cancer Ireland became a registered charity in 2025. It operates on an entirely voluntary basis by individuals who have been personally impacted by pancreatic cancer.

About Us

leaders-with-ryan-turbidy-01
leaders-01

Who are we

rachel-duquesnois-01

Rachel Duquesnois

Chairperson

niall-rochford-01

Niall Rochford

Director

pamela-deasy-01

Pamela Deasy

Director

leaders-02

Our Vision

An Ireland where everyone with Pancreatic Cancer survives and thrives.

Our Mission

To unapologetically demand a significant increase in survival rates for people with Pancreatic Cancer and improve the experience of those with Pancreatic Cancer, their families and support networks.

We do this by working collaboratively with those diagnosed with Pancreatic Cancer, their families, support networks, volunteers, health and social care professionals and researchers.

Our Aims

Our Objectives

1.

Raise awareness about Pancreatic Cancer:

  • among GPs by providing CPD training and online resources in collaboration with the Irish College of General Practitioners
  • among the general public by providing information online and on social media.

2.

Advocate for better healthcare in ways that enable patients’ voices to be heard, on issues such as:

  • better pathways to treatment
  • standards on referral and treatment timescales
  • tumour profiling and setting up of a Biobank
  • establishment of a screening programme and
  • funding for clinical trials.

3.

Develop a range of supports for people with Pancreatic Cancer, their families and their support networks, which will include:

  • providing literature in healthcare settings
  • developing online resources
  • funding hospital-based Pancreatic Cancer nurses

4.

Support research into Pancreatic Cancer and its treatment, which will include but is not limited to:

  • funding a patient survey to gather data on symptoms, wait times and patient experience
  • funding the setting up of a Pancreatic Cancer Biobank to inform treatment, inform prognosis, decide eligibility for clinical trials and indicate familial risk in line with international best practice
  • funding the setting up of a national database of people with Pancreatic Cancer.